Cite
Atrial fibrillation after closure of patent foramen ovale in the REDUCE clinical study.
MLA
Andersen, Asger, et al. “Atrial Fibrillation after Closure of Patent Foramen Ovale in the REDUCE Clinical Study.” Catheterization & Cardiovascular Interventions, vol. 99, no. 5, Apr. 2022, pp. 1551–57. EBSCOhost, https://doi.org/10.1002/ccd.30019.
APA
Andersen, A., Matzen, K. L., Andersen, G., Settergren, M., Sjostrand, C., Iversen, H. K., Roine, R. O., Hildick, S. D., Spence, J. D., Rhodes, J. F., Kasner, S. E., Sondergaard, L., & Nielsen, K. J. E. (2022). Atrial fibrillation after closure of patent foramen ovale in the REDUCE clinical study. Catheterization & Cardiovascular Interventions, 99(5), 1551–1557. https://doi.org/10.1002/ccd.30019
Chicago
Andersen, Asger, Kristina Laut Matzen, Grethe Andersen, Magnus Settergren, Christina Sjostrand, Helle K. Iversen, Risto O. Roine, et al. 2022. “Atrial Fibrillation after Closure of Patent Foramen Ovale in the REDUCE Clinical Study.” Catheterization & Cardiovascular Interventions 99 (5): 1551–57. doi:10.1002/ccd.30019.